Essure Information

Essure Variance E2020002 Final Analysis Report (01-JUN-2020 to 31-MAR-2021) (PDF 525.51 KB)

Essure Variance E2020002 Quarterly Analysis Report 3 (01-DEC-2020 to 28-FEB-2021) (PDF 454.67 KB)

Essure Variance E2020002 Quarterly Analysis Report 2 (01-SEP-2020 to 30-NOV-2020) (PDF 339.28 KB)

Essure Variance E2020002 Quarterly Analysis Report 1 (01-JUN-2020 to 31-AUG-2020) (PDF 316.4 KB)

Bayer Statement on Essure Variance Letter from Food and Drug Administration (FDA) – April 24, 2020 (PDF 171.39 KB)

News Release: Bayer to voluntarily discontinue U.S. sales of Essure at end of 2018 for business reasons - July 20, 2018 (PDF 105.92 KB)

News Release: Bayer reaffirms safety profile of Essure - July 27, 2018 (PDF 30.95 KB)

News Release: Bayer Fact Checks Netflix’s The Bleeding Edge - July 27, 2018 (PDF 39.82 KB)

Washington Post: An Open Letter to Patients and Providers About Essure - July 27, 2018 (PDF 179.81 KB)

Essure: Frequently Asked Questions - July 29, 2018 (PDF 51.3 KB)